キナーゼの臨床成功!


Human Clinical Trial Case2:

Age:80 Gender: Female

Diagnosis:1.Hepatocelluar carcinoma status post transarterial embolization.

2.Right upper lung non-small cell lung cancer, adenocarcinoma.

96/04/27

96/10/31

96/11/14

96/11/15

97/02/26

97/03

Size of liver tumor

3.1 cm

-

-

3 x 2.5 cm

size of lung tumor

5 cm

3.6 cm

GPT

-

-

-

78

57

-

GOT

-

-

-

70

67

-

AFP

-

172.1

106.9

-

31.3

-

Summary

Major finding in Lee’s pathological diagnosis on April 27th, 2007 is the favored multi-nodular HCCs at both lobes, and the largest one is about 3.1 cm. At first the patient was treated by Iressa anti-cancer drug, but it caused the severe allergy drug reaction. Moreover, in the beginning of the October, 2007, Lee was diagnosed that there is a sizeable tumor on eyes, which was originally planed to remove it in the middle of November. The size of the lung tumor was 5 cm. Instead, without other treatments, Lee changed to use the anti-cancer peptide drug in our company. On October 31st, Lee’s AFP was tested 172.1 ng/ml, and the following month, on November 14th, the number lowered to 106.9. Besides that, the tumor on eyes totally disappeared. On November 15th, the test result of GPT and GOT were 78 U/L and 70 U/L. However, according to the latest result, which was tested on February 26th, 2008, the multi-tumor has disappeared, and the biggest size of liver tumor is shrunk from 3.1 cm to 3x2.5 cm; furthermore, GPT and GOT are lower to 57 U/L and 67 U/L. Also, the test result of AFP is even lower to 31.3 ng/ml. Moreover, the original lung tumor size was 5 cm was shrunk to 3.6 cm in March 2008. According to the daughter, the patient was asked to check back once a month, and then after using our drug, the patient was asked to check back once in 2 months. Finally, recently the doctor asks the patient to check back once in 3 months. The patient even can take HSR for traveling. It all demonstrates how affective this Anti-cancer peptide drug is.


Safe & Effective Life & Health Biotechnology has created a novel natural therapy for the treatment of cancer. The characteristic of this product is it makes of natural polypeptides, which purified from daily food, not synthesized chemically. After function, it can be digested naturally. The product of L&H biotech, Anti-Kinase, can inhibit the tyrosine kinase activity. The anti-cancer effects of Anti-Kinase are as same as the other chemical tyrosine kinase inhibitors, such as Iressa, Tarceva, and Nexavar, but the required dosage and cost are much lower than these. Anti-Kinase have the highly potential to prolong patients’ life without the serious side effects associated with chemical drugs that have traditionally underpinned the treatment of most cancer. There is no risk of poisoning or side effects. These Food Suppliers not only are non-chemical drugs, but also non-heavy metal residues. The product is guaranteed by SGS Group - Société Générale de Surveillance.

NO PRESERVATIVES ADDED

NO ARTIFICIAL COLOR

NO GLUTEN

Storage and stability Product should be stored at 4C.

For technical supports about this product, please call us at +886-2-26522989 or e-mail us at lh.biotech@msa.hinet.net